VT
VRTX icon

Vise Technologies’s Vertex Pharmaceuticals VRTX Stock Holding History

Vise Technologies’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Hold
5,259
– – 0.05% 320
2025
Q4 		$2.38M Buy
5,259
+1,036
+25% +$447K 0.05% 321
2025
Q3 		$1.65M Sell
4,223
-55
-1% -$23K 0.06% 299
2025
Q2 		$1.9M Buy
+4,278
New +$1.97M 0.08% 269
2024
Q4 		$1.13M Buy
2,809
+1,646
+142% +$763K 0.09% 219
2024
Q3 		$541K Buy
+1,163
New +$559K 0.07% 274

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vise Technologies's VRTX Position: Q1 2026 in Review

Vise Technologies held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 5,259 shares worth $2.38M. The position accounts for 0.05% of the portfolio, ranked #320.

Vise Technologies first reported a position in VRTX in Q3 2024 and has held it in 6 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Vise Technologies held 5,259 shares of Vertex Pharmaceuticals worth $2.38M as of Q1 2026.
  • Vise Technologies left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.05% of Vise Technologies's portfolio in Q1 2026, its #320 holding.
  • Vise Technologies first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.